Verona Pharma Share Discussion Threads

[insideryou] 31/3/2020 13:17

Why the thumbs down. At least give me your reasons?

[ohisay] 31/3/2020 10:35

Interesting to see how this does this afternoon re Nasdaq listing.

[insideryou] 31/3/2020 10:07

Love the report and the potential for this market.

[ohisay] 31/3/2020 09:02

The good thing is that as well as being a bronchodilator the drug is an anti imflammatory .Thats quite a good USP!

[tomboyb] 31/3/2020 08:54

...

I agree -

[insideryou] 31/3/2020 08:48

Addressing an area of the body crucial to the corona virus... Still under the radar.

[ohisay] 31/3/2020 07:12

For what they have, at the current price, they are simply undervalued.
£30m cash at the end of December.

[tomboyb] 20/3/2020 08:52

Someone clearly has bough in today -

(not me) -

But i know RPL554 from a while back - (with another investor)

[ohisay] 19/3/2020 10:24

Science here pretty compelling and market cap not much above cash .So can they find themselves a partner this year?.
I keep adding on weakness.

[bonzo] 18/3/2020 18:47

Do they follow the BB?

[bonzo] 18/3/2020 18:46

Let's hope these guys have the wit to try it in covid 19 patients...

[ohisay] 04/3/2020 15:50

Conference call confirmed go it alone phase 3 funding is 125m dollars.
So to say they need a partner is putting it mildly.

[mortimer7] 27/2/2020 09:37

Audit related services £267k!!!

For a company with no revenue, all they have to do is add up what's been spent.
Directors need to get a grip & preserve cash frittered on overheads.

[haff1] 27/2/2020 09:20

...report looks to me like a need this year for more dilution of shares/ money raising to balance the likely burn on funds....so it's another jam tomorrow report....it still needs to be taken up by a large pharma to see any progress in our investments imho?

[haff1] 24/2/2020 10:42

....and the share price continues to disappoint and fall!!!

[bioking] 20/2/2020 15:21

DNL about to explode , Institutional investor added 1 million shares this week . LOTS of BIG NEWS around the corner =10+ BAGGER GEM RALLLYYYYYYYYYYYY

Diurnal (DNL)
Market Cap £27 M
Price: 31p



Upcoming Catalysts:

MAA-Acceptance for Chronocort in February/March 2020

Alkindi approval in Israel expected in 2Q 2020

Alkindi approval in Australien expected in 2Q 2020

US-Partnership for Alkindi & Chronocort expected in 1H 2020

Alkindi & Chronocort Partnership for Asia für Japan und China

US-Approval for Alkindi expected in 4Q 2020

EU Approval for Chronocort expected in 4Q/1Q 2020/21


Investment summary:Alkindi, a cortisol replacement therapy designed for children under 18 years of age, is DNL’s first product on the market. It is expected to be followed by Chronocort for adults – a larger market – which now has a clear pathway for regulatory approval in both Europe and the US. Despite this, the share price is still languishing well below valuations determined by peer group and DCF (202p) analyses

[bbonsall] 18/2/2020 09:12

In my opinion the mms are cashing in by buying at 60p when they know it is 70p in America. You watch the offer go up as we approach 2.30 so the profit can be pocketed!

[bbonsall] 17/2/2020 11:38

Pure mm opportunism today! NASDAQ is not open today and closed at equivalent of 70p last Friday. So why drop the price today? Maybe because the mms are not threatened by any further rise on NASDAQ today. Nothing changes!

[ohisay] 14/2/2020 09:59

At least the spread is a little more sensible!

[bonzo] 14/2/2020 08:18

My buy of 8000 showing as a sell!

[matt123d] 14/2/2020 08:04

Taken some profits here, 25k at 66p. Hasn't been printed yet. Will hold the rest.